Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis
Open Access
- 30 June 2021
- Vol. 13 (13), 3274
- https://doi.org/10.3390/cancers13133274
Abstract
External factors, such as the coronavirus disease 2019 (COVID-19), can lead to cancellations and backlogs of cancer surgeries. The effects of these delays are unclear. This study summarised the evidence surrounding expectant management, delay radical prostatectomy (RP), and neoadjuvant hormone therapy (NHT) compared to immediate RP. MEDLINE and EMBASE was searched for randomised controlled trials (RCTs) and non-randomised controlled studies pertaining to the review question. Risks of biases (RoB) were evaluated using the RoB 2.0 tool and the Newcastle–Ottawa Scale. A total of 57 studies were included. Meta-analysis of four RCTs found overall survival and cancer-specific survival were significantly worsened amongst intermediate-risk patients undergoing active monitoring, observation, or watchful waiting but not in low- and high-risk patients. Evidence from 33 observational studies comparing delayed RP and immediate RP is contradictory. However, conservative estimates of delays over 5 months, 4 months, and 30 days for low-risk, intermediate-risk, and high-risk patients, respectively, have been associated with significantly worse pathological and oncological outcomes in individual studies. In 11 RCTs, a 3-month course of NHT has been shown to improve pathological outcomes in most patients, but its effect on oncological outcomes is apparently limited.This publication has 80 references indexed in Scilit:
- Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomyBMC Urology, 2012
- Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH databaseThe Prostate, 2012
- Can We Stop Prostate Specific Antigen Testing 10 Years After Radical Prostatectomy?Journal of Urology, 2011
- Delay of Surgery in Men With Low Risk Prostate CancerJournal of Urology, 2011
- Long‐term follow‐up of 3‐month neoadjuvant hormone therapy before radical prostatectomy in a randomized trialBJU International, 2010
- The discovery of prostate‐specific antigenBJU International, 2007
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Reasonable Delay of Surgical Treatment in Men with Localized Prostate Cancer - Impact on Prognosis?European Urology, 2005
- 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate CancerEuropean Urology, 2000
- Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II studyBJU International, 1997